Model policy guidelines for opioid addiction treatment in the medical office

Pain Physician

Volumn 6, Issue 2, 2003, Pages 217-221

  Barrett, George C ^c   Benjamin, Regina M ^c   Blaine, Jack ^c   Burnett, W Joseph ^c   Campos, Carlos ^c   Cichon, Charles ^c   Czechowicz, Dorynne ^c   Dilts, Stephen L ^c   Fleming III, William H ^c   Good, Patricia M ^c   Harp, William L ^c   Keyes, D Christopher ^a   Ling, Walter ^b   Lubell, Ira ^c   Manlandro, James J ^c   McGinnis, Tom ^c   McNicholas, Laura F ^c   Morrissey, Daniel W ^c   Suchinsky, Richard T ^c   Thomas Jr , R Russell ^c   Trachtenberg, Alan ^c   Van Komen, George J ^c   Wesson, Donald R ^c   Williams, Donald H ^c   Levy, Bruce A ^c   Robin, Lisa ^c   Hoferer, Jeanne ^c   more..

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; METHADONE; NALOXONE; NALTREXONE; OPIATE; OPIATE ANTAGONIST;

ANAMNESIS; CONSULTATION; DISEASE CLASSIFICATION; DRUG APPROVAL; DRUG RECEPTOR BINDING; FOOD AND DRUG ADMINISTRATION; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; INFORMED CONSENT; LAW; MEDICAL PRACTICE; NOTE; OPIATE ADDICTION; PATIENT COMPLIANCE; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRESCRIPTION; TREATMENT INDICATION;

EID: 0042063650     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (3)

1. Drug Addiction Treatment Act of 2000, Public Law 106-310, Title XXXV, Section 3501 and 3502.
2. Buprenorphine Clinical Practice Guidelines, Table 3-1.
3. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Text Revision, Washington, D.C.